Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354118 · ClinicalTrials.gov registry record · NA
Maintaining Patency in Implanted Port Catheters
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT02354118: Completed NA study, sponsored by TriHealth.
NCT02354118 is a NA study that has completed, run by TriHealth. The registered enrollment target is 436 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02354118, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.
Primary Outcome
Number of participants who had a first complete occlusion (Blockage) within 1 year
Interventions
- OTHER Heparinized saline catheter flush
- OTHER Saline-only catheter flush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-12-17 |
| Phase | NA |
What the finished NCT02354118 record still lists
NCT02354118 is an interventional study that assigns participants to a tested intervention. The registered 436 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Heparinized saline catheter flush is the first listed.
NCT02354118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02354118 about?
NCT02354118 is a clinical study titled "Maintaining Patency in Implanted Port Catheters". The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose po...
What is the current status of trial NCT02354118?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2013-01. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT02354118?
The interventions under investigation include: Heparinized saline catheter flush (OTHER), Saline-only catheter flush (OTHER).
Who is sponsoring clinical trial NCT02354118?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02354118's enrollment target sits among peer trials
436 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- NCT07318493 · 436 participants · NA
Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia